- Home
- SSY vs CDIO Comparison
SSY vs CDIO Comparison
Compare SSY & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- CDIO
- Stock Information
- Founded
- SSY 1959
- CDIO 2017
- Country
- SSY United States
- CDIO United States
- Employees
- SSY N/A
- CDIO N/A
- Industry
- SSY Hospital/Nursing Management
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SSY Health Care
- CDIO Health Care
- Exchange
- SSY Nasdaq
- CDIO Nasdaq
- Market Cap
- SSY 6.8M
- CDIO 6.4M
- IPO Year
- SSY N/A
- CDIO N/A
- Fundamental
- Price
- SSY $1.04
- CDIO $3.88
- Analyst Decision
- SSY
- CDIO Buy
- Analyst Count
- SSY 0
- CDIO 1
- Target Price
- SSY N/A
- CDIO $60.00
- AVG Volume (30 Days)
- SSY 235.5K
- CDIO 39.1K
- Earning Date
- SSY 09-29-2025
- CDIO 08-11-2025
- Dividend Yield
- SSY 9.62%
- CDIO N/A
- EPS Growth
- SSY N/A
- CDIO N/A
- EPS
- SSY 0.25
- CDIO N/A
- Revenue
- SSY $31,094,000.00
- CDIO $19,902.00
- Revenue This Year
- SSY N/A
- CDIO $1,434.82
- Revenue Next Year
- SSY N/A
- CDIO $4,661.91
- P/E Ratio
- SSY $4.24
- CDIO N/A
- Revenue Growth
- SSY N/A
- CDIO N/A
- 52 Week Low
- SSY $0.62
- CDIO $3.22
- 52 Week High
- SSY $1.91
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- SSY 46.09
- CDIO 42.13
- Support Level
- SSY $1.02
- CDIO $3.82
- Resistance Level
- SSY $1.44
- CDIO $4.42
- Average True Range (ATR)
- SSY 0.15
- CDIO 0.35
- MACD
- SSY -0.01
- CDIO -0.01
- Stochastic Oscillator
- SSY 16.67
- CDIO 20.93
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.